A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.
Author: The Medical News
RPB awards $220,000 to SUNY Downstate for eye research
Capping SUNY Downstate Medical Center’s growth into a major center for eye research, Research to Prevent Blindness (RPB) has awarded SUNY Downstate a four-year challenge grant of $220,000 to spur the development of advanced research into the causes, tr…
Study shows 50% reduction in blindness and severe visual loss in Denmark
Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World. A report from the University of Copenhagen and Glostrup Hospital in Denmark published today shows the number of new cases of blindness and severe visua…
Elsevier to publish The Ocular Surface that focuses on external eye and vision
Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce newly acquiring The Ocular Surface, a peer-reviewed journal focusing on the external eye and vision. As per January 2012 E…
Vitamin D could prevent age related eye degeneration: Study
A new study showed that increased vitamin D intake can help to prevent age-related diseases, in particular loss of vision and blindness.
SERI researchers receive NEI grant to understand origins of eye allergies
The National Eye Institute has awarded researchers at the Schepens Eye Research Institute, a subsidiary of Mass. Eye and Ear, a five year-grant totaling more than $2.4 million to understand the origins of eye allergies.
New computational modeling methods book for ophthalmologists
Dr. Sumeet Dua, the Upchurch Endowed Professor of Computer Science and coordinator of information technology research at Louisiana Tech University, has co-edited a new book on computational modeling methods that can help ophthalmologists develop innova…
Vitamin D supplements can fight against age-related macular degeneration
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found that vitamin D reduces the effects of ageing in mouse eyes and improves the vision of older mice significantly. The researchers hope that this might mea…
ForSight VISION4 to receive first milestone payment for Lucentis drug delivery device
Genentech, a member of the Roche Group, today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company’s investigational drug delivery device, designed to provide sust…
Ocular drug delivery: DSM awarded membership in PANOPTES EU Funded Consortium
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step…
Viewpoints: Renewing the call for a public option; Keep all justices on health law case
In Washington, the three major health insurers -; Premera Blue Cross, Regence BlueShield and Group Health Cooperative -; are sitting on a total of more than $2.4 billion above and beyond what they expect to ever pay out in claims.
JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema
KalVista Pharmaceuticals and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease.
Clearside Biomedical receives $4M venture capital investment
Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that has received a $4 million ve…
Cutera to purchase assets of IRIDEX’ global aesthetic business
Cutera, Inc. and IRIDEX Corporation today announced that the companies have entered into a binding agreement for Cutera to purchase certain assets of IRIDEX’ global aesthetic business for approximately $5.1 million.
Study finds risk factors associated with exfoliation syndrome
When it comes to whether or not you will develop exfoliation syndrome (ES) — an eye condition that is a leading cause of secondary open-angle glaucoma and increased risk of cataract as well as cataract surgery complications — age, gender and where yo…
ThromboGenics submits ocriplasmin BLA with FDA to treat symptomatic VMA
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that it has submitted a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for ocriplasmin Intravitre…
FDA clears OptiMedica’s Catalys Precision Laser System
Global ophthalmic company OptiMedica Corp. has announced the U.S. Food and Drug Administration (FDA) 510(k) market clearance of its Catalys Precision Laser System, a next generation laser cataract surgery system that brings unequaled precision and accu…
Azithromycin shows promise against trachoma-related blindness
A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually. This randomized study on trachoma, the leading cause of infection-caused blindness in the world, could poten…
New pharma title from iSmithers ‘Update on Polymers for Ocular Drug Delivery’
The eye is the most easily accessible site for topical administration of a medication. Drugs are commonly applied to the eye for localised action on the surface or in the interior of the eye. A major problem in ocular therapeutics is the attainment of …
FDA, other organizations unveil program to monitor cataract surgery devices
The U.S. Food and Drug Administration and other government and professional organizations today unveiled a program to monitor medical devices used in cataract surgery in an effort to stem outbreaks of a rare, inflammatory condition associated with the …